Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ludwig Vincent

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The AAPS Journal|October 9, 2020
Simultaneous Ivabradine Parent-Metabolite PBPK/PD Modelling Using a Bayesian Estimation MethodJennifer Lang, Ludwig Vincent, Marylore Chenel, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 14, 2021
Reduced physiologically-based pharmacokinetic model of dabigatran etexilate-dabigatran and its application for prediction of intestinal P-gp-mediated drug-drug interactionsJennifer Lang, Ludwig Vincent, Marylore Chenel, et al.
Clinical Pharmacology and Therapeutics|December 7, 2020
Impact of Hepatic CYP3A4 Ontogeny Functions on Drug-Drug Interaction Risk in Pediatric Physiologically-Based Pharmacokinetic/Pharmacodynamic Modeling: Critical Literature Review and Ivabradine Case StudyJennifer Lang, Ludwig Vincent, Marylore Chenel, et al.
Journal of Pineal Research|March 10, 2010
Molecular and cellular pharmacological properties of 5-methoxycarbonylamino-N-acetyltryptamine (MCA-NAT): a nonspecific MT3 ligandLudwig Vincent, William Cohen, Philippe Delagrange, et al.
Psychopharmacology|September 14, 2011
Involvement of histamine receptors in the atypical antipsychotic profile of clozapine: a reassessment in vitro and in vivoMarie Humbert-Claude, Elisabeth Davenas, Florence Gbahou, et al.
British Journal of Pharmacology|January 25, 2006
Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivativesFlorence Gbahou, Ludwig Vincent, Marie Humbert-Claude, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 24, 2023
A comprehensive evaluation in clinic and physiologically-based pharmacokinetic modeling and simulation to confirm lack of cytochrome P450-mediated drug-drug interaction potential for pomotrelvirZiping Yang, Nathalie Rioux, Ludwig Vincent, et al.
Molecular Pharmacology|December 24, 2010
Identification and mechanism of action of the acylguanidine MRT-83, a novel potent Smoothened antagonistHermine Roudaut, Elisabeth Traiffort, Tatiana Gorojankina, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 4, 2018
Direct and quantitative evaluation of the major human CYP contribution (fmCYP) to drug clearance using the in vitro Silensomes™ modelYannick Parmentier, Corinne Pothier, Nicola Hewitt, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The AAPS Journal|October 9, 2020
Simultaneous Ivabradine Parent-Metabolite PBPK/PD Modelling Using a Bayesian Estimation MethodJennifer Lang, Ludwig Vincent, Marylore Chenel, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 14, 2021
Reduced physiologically-based pharmacokinetic model of dabigatran etexilate-dabigatran and its application for prediction of intestinal P-gp-mediated drug-drug interactionsJennifer Lang, Ludwig Vincent, Marylore Chenel, et al.
Clinical Pharmacology and Therapeutics|December 7, 2020
Impact of Hepatic CYP3A4 Ontogeny Functions on Drug-Drug Interaction Risk in Pediatric Physiologically-Based Pharmacokinetic/Pharmacodynamic Modeling: Critical Literature Review and Ivabradine Case StudyJennifer Lang, Ludwig Vincent, Marylore Chenel, et al.
Journal of Pineal Research|March 10, 2010
Molecular and cellular pharmacological properties of 5-methoxycarbonylamino-N-acetyltryptamine (MCA-NAT): a nonspecific MT3 ligandLudwig Vincent, William Cohen, Philippe Delagrange, et al.
Psychopharmacology|September 14, 2011
Involvement of histamine receptors in the atypical antipsychotic profile of clozapine: a reassessment in vitro and in vivoMarie Humbert-Claude, Elisabeth Davenas, Florence Gbahou, et al.
British Journal of Pharmacology|January 25, 2006
Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivativesFlorence Gbahou, Ludwig Vincent, Marie Humbert-Claude, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 24, 2023
A comprehensive evaluation in clinic and physiologically-based pharmacokinetic modeling and simulation to confirm lack of cytochrome P450-mediated drug-drug interaction potential for pomotrelvirZiping Yang, Nathalie Rioux, Ludwig Vincent, et al.
Molecular Pharmacology|December 24, 2010
Identification and mechanism of action of the acylguanidine MRT-83, a novel potent Smoothened antagonistHermine Roudaut, Elisabeth Traiffort, Tatiana Gorojankina, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 4, 2018
Direct and quantitative evaluation of the major human CYP contribution (fmCYP) to drug clearance using the in vitro Silensomes™ modelYannick Parmentier, Corinne Pothier, Nicola Hewitt, et al.
Pageof 1